Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre
Clinical Endocrinology · 2025
DOI: 10.1111/cen.70026 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Iván Muñoz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
Noninvasive follicular thyroid neoplasia with papillary‐like nuclear characteristics (NIFTP) is characterised by an indolent behaviour and was defined in 2016 to avoid overtreatment in differentiated thyroid cancer (DTC).
Objectives
To report the clinicopathological characteristics and outcomes of patients with NIFTP treated at a Chilean centre between 2016 and 2023.
Design
Observational retrospective study.
Methods
Of 1103 patients with thyroid neoplasia treated with surgery, 104 (9.42%) had NIFTP. Clinicopathological variables were recorded, including ultrasound characteristics, fine‐needle aspiration biopsy (FNAB) results, genetic testing when available, type of surgery, tumour size, and follow‐up data.
Results
Of 104 patients, 85 (81.7%) were female, age of 44 ± 14.2 years and a median tumour size of 1.7 cm (range 0.1–7.1). Eighty‐six (82.7%) had available preoperative staging ultrasound: 1 (1.2%), 39 (45.3%), 38 (44.2%), and 8 (9.3%) were ACR‐TIRADS 2, 3, 4, and 5, respectively. Sixteen (15%) NIFTP were incidental, which were smaller than non‐incidental NIFTP (median 0.4 cm (0.1–2.2) vs. 1.9 cm (0.6–7.1), p < 0.001). Of the 86 FNAB results available, 2 (2.3%), 10 (11.6%), 20 (23.3%), 24 (27.9%), and 30 (34.9%) were Bethesda I, II, III, IV, and V, respectively. Forty‐three patients (41.3%) were treated with lobectomy, 58 (55.8%) with total thyroidectomy (TT), and only 3 (2.9%) with TT and lymph node dissection. In Bethesda II patients, surgery was indicated in cases of nodule growth, showing a larger tumour size than other Bethesda categories (3.0 ± 1.4 vs. 1.8 ± 1.02 cm, p = 0.015). ThyroidPrint® was performed in 12 patients with Bethesda III or IV, resulting suspicious in 11 (92%): of these, 8 (67%) underwent lobectomy. There were no significant differences between lobectomy and TT regarding sex, ACR‐TIRADS, tumour size, or ThyroidPrint® results. Twelve (11.5%) were multifocal and 5 (4.8%) bilateral. Fifty‐two patients (54%) were followed for ≥ 1 year using follow‐up criteria and response to treatment for low‐risk DTC recurrence. Thirty‐four (65%) had excellent response, 15 (28.8%) indeterminate (13 (25%) by biochemical criteria and 2 (3.8%) by ultrasound), 3 (5.7%) incomplete biochemical (2 (3.8%) due to elevated Tg and 1 (1.9%) due to elevated anti‐Tg antibodies), and none with incomplete structural response. There were no differences between lobectomy and TT ± lymph node dissection regarding the type of response. At the end of the follow‐up, there were no deaths, and no new interventions were required due to recurrence.
Conclusions
In this series, NIFTP showed indolent behaviour and excellent prognosis. Ultrasonographically, 90% presented as ACR‐TIRADS 3 or 4, with less than 10% as ACR‐TIRADS 5. Regarding FNAB, nearly half were indeterminate, one‐third were Bethesda V, and none Bethesda VI. No significant differences in clinical outcomes were found between lobectomy and TT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
- CETREN: Centro de estudios traslacionales de Endocrinología UC, Santiago, Chile.
- Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
- Department of Radiology, Nuclear Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Lorena Mosso Gómez, José Miguel Domínguez
Zitieren
APA
Muñoz, I., Solórzano, M., Fuentes, I., González, J. M., Acevedo, J. F., Rademacher, C. R., Giavio, J. V., Torres, R. C., Miranda, P. M., Díaz, H. G., Solar, A., Olivos, F. C., Gómez, L. M., Franco, N. L., & Domínguez, J. M. (2025). Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre. Clinical Endocrinology. https://doi.org/10.1111/cen.70026
Vancouver
Muñoz I, Solórzano M, Fuentes I, González JM, Acevedo JF, Rademacher CR, et al. Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre. Clinical Endocrinology. 2025. doi:10.1111/cen.70026
BibTeX
@article{Muoz2025,
author = {Muñoz, Iván and Solórzano, Marlín and Fuentes, Ignacio and González, José Miguel and Acevedo, Joel Falcón and Rademacher, Catalina Ruiz and Giavio, Joaquín Viñambres and Torres, Rodolfo Cabello and Miranda, Pablo Montero and Díaz, Hernán González and Solar, Antonieta and Olivos, Francisco Cruz and Gómez, Lorena Mosso and Franco, Nicole Lustig and Domínguez, José Miguel},
title = {Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.70026}
}
EUVIMED